DaShenLin Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 16,291.56 million compared to CNY 14,262.22 million a year ago. Revenue was CNY 16,759.34 million compared to CNY 14,582.87 million a year ago. Net income was CNY 791.23 million compared to CNY 1,062.18 million a year ago. Basic earnings per share from continuing operations was CNY 0.8333 compared to CNY 1.125 a year ago. Diluted earnings per share from continuing operations was CNY 0.8333 compared to CNY 1.125 a year ago.